Head-to-head for women
CoreAge Rx vs SkinnyRx
CoreAge Rx and SkinnyRx both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Metabolic-Fit Score — our women's-health rubric.
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.
CoreAge Rx
Higher scoreMetabolic-Fit 86/100 · Grade B
Metabolic-Fit / 100
Best for: Someone considering both compounded injection options who wants an advertised flat price without a required subscription and will confirm the exact prescription, state access and refund terms.
Visit CoreAge RxSkinnyRx
Metabolic-Fit 37/100 · Grade C
Metabolic-Fit / 100
Best for: Mothers willing to verify SkinnyRx's compounding and ingredient claims for themselves rather than take its labels or marketing at face value — the FDA found the site misrepresents who actually compounds these products and implies an FDA-approved status they don't have. Read the FDA's letter before you weigh in the tablet option or the first-month offer.
Visit SkinnyRxThe verdict for women
CoreAge Rx edges out SkinnyRx on the Metabolic-Fit Score, 86 to 37 (B vs C). Someone considering both compounded injection options who wants an advertised flat price without a required subscription and will confirm the exact prescription, state access and refund terms.
SkinnyRx is still a genuine option — a $99 first month for either injection, with the ongoing price shown only at checkout, and a real non-injection option most providers we review skip: sublingual tablets for both molecules — but the FDA issued its parent entity, Lean Rx, Inc., a warning letter on 02/20/2026 (ref. 717989) for mislabeling itself as the compounder on its own product images and for marketing language implying its compounded products share FDA-approved status with Mounjaro and Zepbound, which they don't. Confirmed directly on FDA.gov; SkinnyRx's own site never mentions it. Weigh the six women's-health factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
Price highlights compare average monthly budgets, using 52 weeks ÷ 12 months for weekly cycles. Quoted charges retain their billing units; unknown periods and fee-only or prepaid quotes do not compete.
| Detail | CoreAge Rx | SkinnyRx |
|---|---|---|
| Metabolic-Fit Score | 86/100 · B | 37/100 · C |
| Overall rank | #1 | #269 |
| Semaglutide | $79/mo advertised flat price; confirm prescription quantity and total | $99 first month; standing monthly price not published before checkout |
| Tirzepatide | $129/mo advertised flat price; confirm prescription quantity and total | $99 first month; standing monthly price not published before checkout |
| Coverage | US service; state restrictions vary by therapy — confirm during intake | Not disclosed on the public site we reviewed |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
The decision beyond the score
SkinnyRx's $99 is a first-month offer
SkinnyRx publicly advertises the first month of either compounded injection at $99. Its standing monthly price appears only at checkout after the quiz, rather than in the public offer. CoreAge's current public offer advertises flat monthly prices of $79 for semaglutide and $129 for tirzepatide across doses, with no membership fee. Confirm the prescribed quantity, total due and repurchase terms; this public offer is not a personally verified checkout. SkinnyRx’s entry figure does not establish its later bill, while CoreAge advertises the same monthly rate across doses; confirm the selected purchase details rather than assuming a price tie. SkinnyRx's missing renewal amount prevents a defensible comparison over several months. A reader should not project that promotional amount into a treatment budget.
SkinnyRx also offers sublingual tablets, with first-month amounts of $149 for semaglutide and $199 for tirzepatide. These are distinct forms with their own unshown continuing prices. CoreAge's listed programs do not provide that oral alternative. If avoiding injections is important, ask the prescriber about the exact compounded formulation and its evidence, then obtain the renewal quote. A tablet offer is not a substitute for knowing which medicine is appropriate or what it will cost after the first supply. The amount advertised for an injection should not be transferred to the tablet plan.
The parent company's warning letter should be visible
The FDA issued SkinnyRx's parent, Lean Rx, Inc., warning letter #717989 on February 20, 2026. The concerns include product images identifying the company as the compounder and marketing suggesting compounded products shared FDA-approved status with brands such as Mounjaro and Zepbound. That is material context for evaluating the platform's product descriptions. It does not mean every compounded seller has received the same letter, and it should not be converted into a statement about a patient's likely outcome. Ask who actually dispenses the prescription and how the particular product is labeled.
Confirm prescribing and dispensing eligibility with SkinnyRx and CoreAge for your address and selected product. Neither is presented as a dedicated postpartum or PCOS clinic, and neither price establishes appropriateness for breastfeeding or pregnancy planning. CoreAge is a featured partner. Confirm CoreAge's quantity, total and repurchase terms before using its advertised monthly offer in a continuing injection budget. SkinnyRx's formulation menu may merit a clinician discussion, but the next payment, supply commitment and state eligibility need to be known before its inexpensive first month becomes a reason to choose it. An attractive entry charge is only one installment in the actual decision.
Based on the public terms documented in the CoreAge Rx review and SkinnyRx review. Each review details the prices and terms. Confirm current terms before paying.
Metabolic-Fit / 100
CoreAge Rx
Metabolic-Fit 86/100 · Grade B
What we like
- Officially linked public offer advertises $79/month semaglutide and $129/month tirzepatide across doses
- Advertises care and free overnight cold shipping within those prices, with no membership fee
- Public offer describes one-time purchases, no required subscription and the same refill price
The caveats
- Main navigation still shows semaglutide from $99, conflicting with the $79 officially linked offer
- A patient-specific prescription quantity and checkout total were not verified; confirm before paying
- State eligibility depends on therapy; nationwide access should not be assumed
Metabolic-Fit / 100
SkinnyRx
Metabolic-Fit 37/100 · Grade C
What we like
- Offers sublingual tablets as a genuine alternative to injections for both molecules — uncommon
- A low first month: $99 for either injection
The caveats
- No state list or exclusions published anywhere on the public site
- Only first-month prices are public; the ongoing monthly price appears at checkout, after the quiz
- No mention anywhere of pregnancy, breastfeeding, postpartum recovery, or PCOS
Some outbound links earn MomMetabolic a referral fee at no added cost to you, walled off from the Metabolic-Fit Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Comparisons close to CoreAge Rx vs SkinnyRx.
- CoreAge Rx vs PCOS Sisters
- CoreAge Rx vs Wellmedr
- CoreAge Rx vs Ro
- CoreAge Rx vs Maven Clinic
- CoreAge Rx vs Wellorithm
- CoreAge Rx vs Hone Health
Or browse the full comparison hub.